acetohexamide
≈ 1 min read
Names in other languages
- lvacetoheksamīds
- Englishacetohexamide
- EspañolAcetohexamida
- shAcetoheksamid
- СрпскиAcetoheksamid
- Italianoacetoesamide
- Portuguêsacetoexamida
- 日本語アセトヘキサミド
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.
Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.
Mechanism of action
Acetohexamide binds to an ATP-sensitive K + (K ATP ) channel on the cell membrane of pancreatic beta cells. This inhibits the outflux of potassium, which causes the membrane potential to become more positive. This depolarization in turn opens voltage-gated calcium channels. The rise in intracellular calcium leads to increased fusion of insulin granulae with the cell membrane, and therefore increased secretion of insulin.
Risks
Sulfonylureas, especially first-generation sulfonylureas such as Acetohexamide, can cause severe hypoglycemia and increase the risk of adverse cardiovascular events.
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1357901449 under CC BY-SA 4.0; modifications have been made.